Pharmosa Biopharm Inc. (PBI) is a world-class biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. With regional/global strategic partnerships, we commercialize our product through 505(b)2 or hybrid applications to regulatory authorities. It is applying our proprietary liposome technology to create an innovative nanoparticle formulation with an existing...
Pharmosa Biopharm Inc. (PBI) is a world-class biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. With regional/global strategic partnerships, we commercialize our product through 505(b)2 or hybrid applications to regulatory authorities. It is applying our proprietary liposome technology to create an innovative nanoparticle formulation with an existing drug. We are focusing on the development of drug-device combination products through 505(b)2 or hybrid regulatory pathways.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.